English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

In vivo online magnetic resonance quantification of absolute metabolite concentrations in microdialysate.

MPS-Authors
/persons/resource/persons206060

Glöggler,  S.
Research Group of NMR Signal Enhancement, MPI for Biophysical Chemistry, Max Planck Society;

Locator
There are no locators available
Fulltext (public)

2526006.pdf
(Publisher version), 943KB

Supplementary Material (public)
There is no public supplementary material available
Citation

Glöggler, S., Rizzitelli, S., Pinaud, N., Raffard, G., Zhendre, V., Bouchaud, V., et al. (2016). In vivo online magnetic resonance quantification of absolute metabolite concentrations in microdialysate. Scientific Reports, 6: 36080. doi:10.1038/srep36080.


Cite as: http://hdl.handle.net/21.11116/0000-0000-2EAD-B
Abstract
In order to study metabolic processes in animal models of diseases and in patients, microdialysis probes have evolved as powerful tools that are minimally invasive. However, analyses of microdialysate, performed remotely, do not provide real-time monitoring of microdialysate composition. Microdialysate solutions can theoretically be analyzed online inside a preclicinal or clinical MRI scanner using MRS techniques. Due to low NMR sensitivity, acquisitions of real-time NMR spectra on very small solution volumes (μL) with low metabolite concentrations (mM range) represent a major issue. To address this challenge we introduce the approach of combining a microdialysis probe with a custom-built magnetic resonance microprobe that allows for online metabolic analysis (1H and 13C) with high sensitivity under continuous flow conditions. This system is mounted inside an MRI scanner and allows performing simultaneously MRI experiments and rapid MRS metabolic analysis of the microdialysate. The feasibility of this approach is demonstrated by analyzing extracellular brain cancer cells (glioma) in vitro and brain metabolites in an animal model in vivo. We expect that our approach is readily translatable into clinical settings and can be used for a better and precise understanding of diseases linked to metabolic dysfunction.